Patient characteristics of the European League Against Rheumatism Scleroderma Trials and Research cohort
| Total | MD (%) | lcSSc | dcSSc | P Value (lcSSc vs dcSSc) | Other | ||
|---|---|---|---|---|---|---|---|
| Patients, n (%) | 7655 (100) | 29 (0.4) | 4481 (58.5) | 2838 (37.1) | 307 (4.0) | ||
| Age (years), mean (SD) | 54.3 (13.8) | 1.8 | 56.6 (13.4) | 51.1 (13.7) | *** | 51.6 (14.0) | |
| Sex | 0.1 | *** | |||||
| Female, % | 86.1 | 90.1 | 79.4 | 88.3 | |||
| Male, % | 13.9 | 9.9 | 20.6 | 11.7 | |||
| Ethnicity | 52.1 | *** | |||||
| Caucasian, % | 89.2 | 92.1 | 84.5 | 86.5 | |||
| Asian, % | 6.2 | 5.0 | 8.4 | 5.6 | |||
| African, % | 2.0 | 1.0 | 3.8 | 1.6 | |||
| Other/not classifiable, % | 2.6 | 1.9 | 3.3 | 6.3 | |||
| BMI (kg/m2), mean (SD) | 24.1 (4.4) | 39.0 | 24.6 (4.5) | 23.5 (4.2) | *** | 24.3 (5.5) |
↵*** p<0.001; newly introduced items (available since online documentation has started) are highlighted slightly greyish (find additional patient characteristics in online supplementary table S2).
BMI, body mass index; dcSSc, diffuse cutaneous systemic sclerosis; lcSSc, limited cutaneous systemic sclerosis; MD, missing data.